Translation of "Swelling substance" in German

Additionally, the pourable solution must contain at least one pore-forming substance (swelling agent) which should be a nonsolvent for PEI.

The U.S. Pat. No. 3,318,990 describes a method for the production of flat viscose fibers, wherein there is admixed to the viscose, on the one side, sodium carbonate and, on the other side, a high-molecular substance swelling in water, e.g., CMC.

While the cell-fiber-framework guarantees the resistance of the connective tissue against tractive forces, the strongly swelling basic substance from proteoglycanes serves the uptake and distribution of compression forces.

The substance swelled up without going into solution during this time.

The natural swelling substances (e.g. alginates) show overall a wide variability between batches.

The sequential release according to the invention (bioavailability) of the active compounds can be achieved by covering, in a customary manner, for example according to Sucker, Fuchs and Speiser, Pharmazeutische Technologie (Pharmaceutical Technology), Stuttgart 1978, page 424, the tablets, pills or granules, which contain as the medicament acetylsalicylic acid or its medically tolerated salts, such as D,L-lysine monoacetylsalicylate, with a coating which contains as the active compound, for example, pentoxifylline, advantageously in combination with swelling agents (muciferous substances), resins, such as polystyrene, or other customary agents promoting tolerability.

In each case, the contrast medium can contain physiologically compatible buffers, stabilizers, substances for matching the osmolality, pharmacologically effective substances, preservatives, flavors and/or swelling substances.

It is also possible to use swelling or expanding substances arranged in the concrete so that after absorbing moisture from the concrete they swell or expand and by means of such expansion a prestressing force is applied to the clamping element.

The start of the main absorption is some time after the time of intake and can largely be controlled via the nature and thickness of the film coating and the nature and amount of the swelling substances.

The sequential release according to the invention (bioavaiability) of the active compounds can be achieved by covering, in a customary manner, for example according to Sucker, Fuchs and Speiser, Pharmazeutische Technologie (pharmaceutical Technology), Stuttgart 1978, page 424, the tablets, pills or granules, which contain as the medicament acetylsalicylic acid or its medically tolerated salts, such as D,L-lysine monoacetylsalicylates, with a coating which contains as the active compound, for example, pentoxifylline, advantageously in combination with swelling agents (muciferous substances), resins, such as polystyrene, or other customary agents promoting tolerability. .

A part of the needed water, stabilizer (molasses and as a comparison, sucrose), and the corresponding additives (hydrotropes, dispersants, emulsifiers, dehairing agents, swelling-inhibiting substances, etc.) were stirred to homogeneity.

The swelling substances may lead via ion exchange processes to reductions in the germ count in the wound region by preventing depolarizations and conduction thereof, or reducing concentration gradients at the cell membrane of organisms or germs.

In the context of the present text the term “primary swelling agent” designates substances which are able to embed themselves in the molecular structure of non-pre-swollen cellulose.

In the context of the present text, the term “secondary swelling agent” designates substances which, if included in cellulose, in step (III) can be replaced by the flavoring substances to be used or included.

The agents according to the present disclosure can moreover contain further active agents, adjuvants, and additives, for example nonionic polymers, silicones, cationic polymers, structuring agents, solvents and solubilizers, fiber-structure-improving active agents, defoamers such as silicones, anti-dandruff active agents, protein hydrolysates, vegetable oils such as macadamia nut oil, kukui nut oil, palm oil, amaranth seed oil, peach kernel oil, avocado oil, olive oil, coconut oil, rapeseed oil, sesame oil, jojoba oil, soy oil, peanut oil, evening primrose oil, and tea tree oil, light-protection agents, substances for adjusting pH, for example usual acids, in particular edible acids, vitamins, provitamins, and vitamin precursors, plant extracts, consistency agents, waxes, further swelling and penetration substances, luster agents such as ethylene glycol mono- and distearate as well as PEG-3 distearate, propellants such as propane/butane mixtures, N 2 O, dimethyl ether, CO 2, and air, and antioxidants.

DE 699 37 920 T2 states that holographic photopolymer layers can change colour when substances swell into the photopolymer layer from adjacent layers, such as adhesive layers, or bleed out of this layer into the adjacent layer.

In order to avoid changes in volume and the associated changes in colour, DE 699 37 920 T2 teaches adding sufficient amounts of the swelling or bleeding substances to the adjacent layers and/or to the photopolymer layer beforehand.

In particular, it is also possible to add to the pigment preparation according to the invention substances which accelerate or assist the breakdown and dissolution of the pigment granules, examples being bulky spherical particles, such as hollow beads, hemispherical beads, swellable substances with a strong swelling power, substances which undergo controlled breakdown and in doing so evolve gases, and/or substances having very high solubility.

These compositions comprise 1 to 12% by weight of a liquid nonionic surfactant, 2 to 70% by weight of builders, and enzymes and a stabilization system which is composed of swelling substances and hydroxypropylcellulose.